Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.52 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.52 |
| ▸ | FABP4 | P15090 | 5/20 | 0.50 |
| ▸ | FABP3 | P05413 | 2/20 | 0.50 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | HTR2B | P41595 | 1/20 | 0.36 |
| ▸ | GABRB1 | P18505 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9064418 | 0.87 | GABRA1 (0.46) | GABRA1GABRB2FABP4FABP3FABP5 | |
| SCHEMBL20285914 | 0.83 | GABRA1 (0.43) | GABRA1GABRB2FABP4FABP3FABP5 | |
| SCHEMBL27480380 | 0.82 | FABP4 (0.60) | GABRA1GABRB2FABP4FABP3FABP5 | |
| SCHEMBL25958539 | 0.79 | GABRA1 (0.41) | GABRA1GABRB2FABP4FABP3FABP5 | |
| SCHEMBL20636510 | 0.79 | LMNA (0.42) | GABRA1GABRB2FABP4FABP3LMNA | |
| SCHEMBL23191826 | 0.77 | GABRA1 (0.35) | GABRA1GABRB2FABP4FABP3FABP5 | |
| SCHEMBL9064395 | 0.77 | GABRA1 (0.52) | GABRA1GABRB2FABP4FABP3FABP5 | |
| SCHEMBL9369688 | 0.77 | FABP4 (0.56) | GABRA1GABRB2FABP4FABP3FABP5 | |
| SCHEMBL19006936 | 0.75 | GABRA1 (0.37) | GABRA1GABRB2FABP4FABP3FABP5 | |
| SCHEMBL20634961 | 0.74 | CA1 (0.35) | GABRA1GABRB2LMNACA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8502002-B2 | Microscope immersion oil | IDEMITSU KOSAN CO., LTD. (JP) | 2013-08-06 | — | — | US | claimed |
| US-5807846-A | TREATING HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS | WARNER-LAMBERT COMPANY (US) | 1998-09-15 | — | — | US | claimed |
| US-4728632-A | ODORLESS | KOCH INDUSTRIES, INC. (US) | 1988-03-01 | — | — | US | claimed |
| EP-0235901-A1 | Solutions and their use in carbonless paper | KOCH INDUSTRIES, INC. (US) | 1987-09-09 | — | — | EP | claimed |
| US-4680056-A | Carbonless paper solvent utilizing triisopropyltoluene | KOCH INDUSTRIES, INC. (US) | 1987-07-14 | — | — | US | claimed |
| US-3969420-A | Process for recovering resorcinol and hydroquinone in mixture | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-07-13 | — | — | US | claimed |
| EP-3988557-B1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND | SAMSUNG ELECTRONICS CO LTD (KR) | 2023-11-22 | — | — | EP | disclosed |
| EP-4198164-A1 | MIXED LAYER, METHOD OF PREPARING THE MIXED LAYER, LIGHT-EMITTING DEVICE, AND ELECTRONIC APPARATUS | Samsung Electronics Co., Ltd. (KR) | 2023-06-21 | — | — | EP | disclosed |
| US-20230165134-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-05-25 | — | — | US | disclosed |
| CN-110072933-B | Tire comprising a polyindane resin and use thereof | 伊士曼化工公司 | 2022-04-05 | — | — | CN | disclosed |
| US-20210376261-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2021-12-02 | — | — | US | disclosed |
| CN-110072962-B | Adhesive comprising a polyindane resin | 伊士曼化工公司 | 2021-10-19 | — | — | CN | disclosed |
| WO-2021181157-A1 | TREATMENT OF CORONAVIRUS INFECTION | REDHILL BIOPHARMA LTD. (IL) | 2021-09-16 | — | — | WO | disclosed |
| US-4680056-A | Carbonless paper solvent utilizing triisopropyltoluene | KOCH INDUSTRIES, INC. (US) | 1987-07-14 | — | — | US | disclosed |
| US-4680056-A | Carbonless paper solvent utilizing triisopropyltoluene | KOCH INDUSTRIES, INC. (US) | 1987-07-14 | — | — | US | disclosed |
| US-4680056-A | Carbonless paper solvent utilizing triisopropyltoluene | KOCH INDUSTRIES, INC. (US) | 1987-07-14 | — | — | US | disclosed |
| US-4347398-A | Process for preparation of 1-methyl-3,5-diisopropyl benzene | TEXACO INC. (US) | 1982-08-31 | — | — | US | disclosed |
| US-4314091-A | Preparation of 1-methyl-3,5-diisopropyl benzene from charge streams containing diisopropyl toluene | TEXACO INC. (US) | 1982-02-02 | — | — | US | disclosed |
| US-4297508-A | BY REACTING CARBON DIOXIDE WITH B-NAPHTHOL, AN ALKALI METAL SALT OF B-NAPHTHOL, AND AN ALKYLBENZENE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1981-10-27 | — | — | US | disclosed |
| US-3993690-A | Method of obtaining aromatic tri-or-tetracarboxylic acids | SUVOROV BORIS VIKTOROVICH | 1976-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230165134-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, TPO | GABRA1 4480/4885GABRB2 4277/4885FABP4 638/4885 |
| US-20210376261-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, TPO | GABRA1 4480/4885GABRB2 4277/4885FABP4 638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.